FDA Injects Just Under $2m to Investigate mRNA COVID-19 Vax-Induced Myocarditis—Led by Dr. Supriya Jain New York Medical College

The U.S. Food and Drug Administration (FDA) has just granted $1,977,031 to a physician-researcher in a five-year effort to investigate the incidence of myocarditis associated with COVID-19 mRNA vaccines.  This research will use advanced cardiovascular imaging, including cardiac MRI (CMR) led by Supriya Jain, MD,  a clinical associate professor of pediatrics and of radiology and clinical education liaison at New York Medical Hospital and Called a Broad Agency Agreement (BAA), Jain leads the study depending on a collaborative research network of clinical investigators across 30 academic trial site locations.

This latest important study is based on previous research led by Jain that started with 63 patients under the age of 21 and diagnosed with myocarditis post-COVID-19 vaccination,  enrolled from across 16 hospitals in America.

Dr. Jain has since then helped organize a substantial investigator trial network involving cardiology and advanced cardiovascular imaging expertise across 30 trial site locations and over 300 patients.

Lead Research/Investigator

Supriya Jain, MD, a clinical associate professor of pediatrics and of radiology and clinical education liaison at New York Medical Hospital, director of pediatric cardiac MRI/advanced cardiovascular imaging at Maria Fareri Children’s Hospital, a major clinical affiliate of NYMC.

Call to Action: To read more about this important study, see the link.

*

Note to readers: Please click the share buttons above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Featured image is from Dr. Rath Health Foundation